Hemoglobin A1c (HbA1c) Testing Devices Market, By Test Type (Laboratory Testing Devices, Point-of-care Testing Devices), By Technology (Ion-Exchange HPLC, Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay, Others), and By Region (North

Hemoglobin A1c (HbA1c) Testing Devices Market, By Test Type (Laboratory Testing Devices, Point-of-care Testing Devices), By Technology (Ion-Exchange HPLC, Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Hemoglobin A1c Testing Devices are used for diagnosis and monitoring of type 1 and type 2 diabetes. Hemoglobin A1c test results reflect the average blood sugar levels of an individual for the past two to three months. Increasing prevalence of diabetes is expected to propel growth of the global hemoglobin A1c testing devices market over the forecast period.
Furthermore, increasing geriatric population, increasing healthcare infrastructure, and high prevalence of undiagnosed diabetes in emerging economies is also expected to propel the market growth during the forecasted period.
Key features of the study:
This report provides in-depth analysis of the Hemoglobin A1c Testing Devices market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global Hemoglobin A1c Testing Devices market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Abbott Laboratories, ARKRAY, Inc., Bio-Rad Laboratories, Inc., Chek Diagnostics (Polymer Technology Systems, Inc.), Danaher Corporation (Beckman Coulter), F. Hoffmann-La Roche Ltd., Menarini Group, Sebia, Siemens Healthcare, Tosoh Corporation, and Trinity Biotech plc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global Hemoglobin A1c Testing Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Hemoglobin A1c Testing Devices market
Detailed Segmentation:
Hemoglobin A1c Testing Devices Market, By Test Type:
Laboratory Testing Devices
Point-of-care Testing Devices
Hemoglobin A1c Testing Devices Market, By Technology:
Ion-Exchange HPLC
Immunoassay
Boronate Affinity Chromatography
Direct Enzymatic Assay
Others
Hemoglobin A1c Testing Devices Market, By Region:
North America
By Test Type:
Laboratory Testing Devices
Point-of-care Testing Devices
By Technology
Ion-Exchange HPLC
Immunoassay
Boronate Affinity Chromatography
Direct Enzymatic Assay
Others
By Country:
U.S.
Canada
Latin America
By Test Type:
Laboratory Testing Devices
Point-of-care Testing Devices
By Technology
Ion-Exchange HPLC
Immunoassay
Boronate Affinity Chromatography
Direct Enzymatic Assay
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Test Type:
Laboratory Testing Devices
Point-of-care Testing Devices
By Technology
Ion-Exchange HPLC
Immunoassay
Boronate Affinity Chromatography
Direct Enzymatic Assay
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Test Type:
Laboratory Testing Devices
Point-of-care Testing Devices
By Technology
Ion-Exchange HPLC
Immunoassay
Boronate Affinity Chromatography
Direct Enzymatic Assay
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Test Type:
Laboratory Testing Devices
Point-of-care Testing Devices
By Technology
Ion-Exchange HPLC
Immunoassay
Boronate Affinity Chromatography
Direct Enzymatic Assay
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Test Type:
Laboratory Testing Devices
Point-of-care Testing Devices
By Technology
Ion-Exchange HPLC
Immunoassay
Boronate Affinity Chromatography
Direct Enzymatic Assay
Others
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Abbott Laboratories*
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
ARKRAY, Inc.
Bio-Rad Laboratories, Inc.
Chek Diagnostics (Polymer Technology Systems, Inc.)
Danaher Corporation (Beckman Coulter)
F. Hoffmann-La Roche Ltd.
Menarini Group
Sebia
Siemens Healthcare
Tosoh Corporation
Trinity Biotech plc.
“*” marked represents similar segmentation in other categories in the respective section.